Table 3.
Auxological and hormonal data of patients with two stimulated GH peaks below 20 mUI/l (GHD level 1 in white), with two peaks below 20 mUI/l and IGF-1 <-1SDS (GHD level 2 in light gray) and with the previous criteria and delta height <0 (GHD level 3 dark gray).
| N | Age range (year) | CGS | CT scan | Height M0 (SDS) | Delta height M6/M12 (SDS) | Delta weight M6/M12 (SDS) | GH peak mUI/l (1) | GH peak mUI/l (2) | IGF-1 M0/M6/M12 (SDS) | Cort peak nmol/l (1/2) |
|---|---|---|---|---|---|---|---|---|---|---|
| 15 | 5–10 | 15 | Swelling | 2.15 | 0.08/0.24 | −0.12/0.17 | 7.78 | 10.7 | −1.11/−0.96/−0.89 | N |
| 34 | 5–10 | 13 | Swelling | 0.53 | 0.16/0.19 | 0.65/0.7 | 13.4 | 17.3 | −1.85/−0.86/−0.96 | N |
| 61 | 5–10 | 15 | No | 2.3 | −0.2/−0.03 | 0.43/1.1 | 15.7 | 13.1 | −0.5/−0.12/1.06 | N |
| 79 | 5–10 | 15 | No | 0.53 | NA/−0.1 | NA/−0.54 | 4.8 | 17.9 | −1.52/NA/−0.84 | N |
| 80 | 10–15 | 15 | Normal | 1.28 | −0.14/−0.22 | −0.17/−0.89 | 13.7 | 19 | −0.47/−1.01/−0.13 | N |
| 12 | 5–10 | 13 | Swelling | NA | NA | −0.46/−0.24 | 6.21 | 14.9 | NA/−0.03/1.7 | N |
| 28 | 5–10 | 15 | SDH | 0.19 | −0.27/−0.23 | 0.04/−0.23 | 14.8 | 10.7 | −0.7/−0.22/−0.83 | N |
| 95 | 5–10 | 13 | Fracture | −0.73 | 0.23/0.09 | 0.28/0.5 | 14.3 | 16.7 | −1.64/−1.52/−1.62 | N |
| 43 | 5–10 | 15 | Fracture | 1.5 | −0.11/−0.23 | −0.6/−0.46 | 12.9 | 11,1 | −1.64/−1.89/−1.98 | 463/507 |
| 63 | 5–10 | 15 | Normal | −0.8 | 0.04/−0.24 | 0.15/−0.24 | 3.9 | 4.92 | −1.93/−1.77/−1.78 | N |
M, male; F, female; imp, impuberism; N, normal; SDH, subdural hematoma.